Katja Sladko

Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes

K. Schwarz, G. Jennings, M. Bachmann, 2014, Molecular therapy. Methods & clinical development.

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.

T. Kündig, G. Jennings, M. Bachmann, 2006, The Journal of allergy and clinical immunology.

Vaccination against GIP for the Treatment of Obesity

M. Bachmann, P. Saudan, P. Wielinga, 2008, PloS one.

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

H. Volk, A. Tissot, G. Jennings, 2007, Journal of hypertension.